Neuro42

About:

Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.

Website: http://neuro42.ai/

Top Investors: Zepp, National Institute of Neurological Disorders and Stroke, Fred Moll, M.D, Shangbay Capital, Zynext Ventures

Description:

Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.

Total Funding Amount:

$28.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2020-01-01

Contact Email:

hello(AT)neuro42.com

Founders:

Amit Vohra, Michael Bartholomew, Nikhil Sadhwani

Number of Employees:

11-50

Last Funding Date:

2024-08-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai